GlassScriptPhysician profile
David Michael Schwitzer
NPI 1285167544
$3,111.46
in general payments reported to CMS, 2019-2025
11 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 85% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $715 · 2024: $935 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,049 · Travel and Lodging: $62.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,048.79 |
| Travel and Lodging | $62.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $1,106.93 | 2023-2025 | |
| Stryker Corporation | $658.96 | 2023-2025 | Na, Medpor, Vsp System, Vsp Cranial |
| Depuy Synthes Sales INC. | $443.02 | 2023-2025 | Trumatch, Matrixmandible |
| Axogen | $324.86 | 2023-2025 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $127.75 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Geistlich Pharma, North America, INC. | $125.52 | 2025 | Biomaterials |
| Straumann USA LLC | $112.97 | 2025 | |
| Smith+Nephew, INC. | $97.07 | 2024 | Stravix |
| Acumed LLC | $77.13 | 2025 | Osteomed |
| Atos Medical INC | $19.98 | 2024 | Provox Life Home Hme |
| Musculoskeletal Transplant Foundation INC. | $17.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schwitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.